Pharmacological Modulation of Dopamine Receptor D2-Mediated Transmission Alters the Metabolic Phenotype of Diet Induced Obese and Diet Resistant C57Bl6 Mice

Abstract EN

High fat feeding induces a variety of obese and lean phenotypes in inbred rodents.

Compared to Diet Resistant (DR) rodents, Diet Induced Obese (DIO) rodents are insulin resistant and have a reduced dopamine receptor D2 (DRD2) mediated tone.

We hypothesized that this differing dopaminergic tone contributes to the distinct metabolic profiles of these animals.

C57Bl6 mice were classified as DIO or DR based on their weight gain during 10 weeks of high fat feeding.

Subsequently DIO mice were treated with the DRD2 agonist bromocriptine and DR mice with the DRD2 antagonist haloperidol for 2 weeks.

Compared to DR mice, the bodyweight of DIO mice was higher and their insulin sensitivity decreased.

Haloperidol treatment reduced the voluntary activity and energy expenditure of DR mice and induced insulin resistance in these mice.

Conversely, bromocriptine treatment tended to reduce bodyweight and voluntary activity, and reinforce insulin action in DIO mice.

These results show that DRD2 activation partly redirects high fat diet induced metabolic anomalies in obesity-prone mice.

Conversely, blocking DRD2 induces an adverse metabolic profile in mice that are inherently resistant to the deleterious effects of high fat food.

This suggests that dopaminergic neurotransmission is involved in the control of metabolic phenotype.